Abstract The inhibitory protein IjBa, encoded by the NFKBIA gene, plays an important role in regulating the activity of nuclear factor-kappa B, a transcription factor which has been implicated in the initiation and progression of cancers. This study aimed to evaluate the association of NFKBIA -826C[T (rs2233406) and -881A[G (rs3138053) polymorphisms with the risk of sporadic colorectal cancer (CRC) in Malaysian population. A case-control study comprising 474 subjects (237 CRC patients and 237 cancer-free controls) was carried out. The polymorphisms were genotyped from the genomic DNA of the study subjects employing PCR-RFLP, followed by DNA sequencing. The association between the polymorphic genotypes and CRC risk was evaluated by deriving odds ratios (ORs) and 95 % confidence intervals (CIs) using unconditional logistic regression analysis. The two polymorphisms were in complete and perfect linkage disequilibrium (D 0 = 1.0, r 2 = 1.0). Overall, no statistically significant CRC risk association was found for the polymorphisms (P [ 0.05). A similar lack of association was observed when the data were stratified according to ethnicity (P [ 0.05). However, stratification by gender revealed a significant inverse association between the heterozygous genotype of the polymorphisms and the risk of CRC among females (OR 0.53, 95 % CI 0.29-0.97, P = 0.04), but not among males (P [ 0.05). In conclusion, the heterozygous genotype of the polymorphisms could contribute to a significantly decreased CRC risk among females, but not males, in the Malaysian population.
Introduction
Colorectal cancer (CRC) accounts for a significant burden of cancer-related morbidity and mortality. Worldwide, it is the third most common cancer in men and the second most common cancer in women [1] . The incidence of colorectal cancer has been increasing over the past decade, especially in developing countries, and in Malaysia, it has emerged as the most common type of cancer among men [2] . The multifactorial nature of the disease suggests that its occurrence is not only due to environmental factors (such as lifestyle and dietary habits), but also a result of genetic factors as well as the interaction between the two [3, 4] .
Among the genetic factors, mutations in high penetrance genes, such as APC, represent a strong determinant for the pathogenesis of the disease. However, such mutations accounts for only a small proportion of all CRC cases [5] , and attempts to identify similar high penetrance genes have been unsuccessful. Therefore, researchers have shifted their attention to the identification of a panel of low penetrance genes, which could modestly modulate the risk of CRC individually, but contribute to a significant risk modification effect when acting together [6] [7] [8] . Such low penetrance genetic variations are relatively common in the general population. Therefore, they contribute to a higher attributable risk of cancer compared to high penetrance genes [9] .
Genetic variations in genes implicated in cancer initiation and progression could modulate the risk of CRC. Inhibitor of kappa B alpha (IjBa), encoded by the NFKBIA gene, is an important inhibitor of nuclear factor-kappa B (NF-jB), a class of pleiotropic transcription factors which act as central regulators in many cancer-related pathways, notably inflammation [10] . In most normal cells, IjBa binds to NF-jB under normal conditions, thereby inactivating the latter [11] . However, such inactivation is often lost in cancer cells, which highlights the importance of IjBa in circumventing oncogenesis [12] [13] [14] [15] [16] [17] [18] . It has been hypothesized that polymorphisms in the promoter region of NFKBIA could lead to transcriptional and functional consequences of the protein product. This could result in the reduced or enhanced effectiveness of IjBa in suppressing NF-jB activity, which could in turn modulate the risk of cancers and other diseases. Two polymorphisms in the promoter region of NFKBIA, namely the -826C[T (rs2233406) and -881A[G (rs3138053) polymorphisms, have been described and their association with the risk of several immune and inflammatory diseases have been investigated [19] [20] [21] [22] [23] [24] . Thus far, however, no study has been undertaken to evaluate the association between the polymorphisms and CRC risk among Malaysians. Hence, we conducted a case-control study with the aims to investigate the frequencies of NFKBIA -826C[T and -881A[G polymorphic genotypes in Malaysian CRC patients and cancer-free controls, as well as to evaluate the association between these polymorphisms and CRC risk in Malaysian population. were cancer-free healthy volunteers who visited the participating hospitals for regular health examination. Controls were frequency matched to cases in terms of gender, age (±5 years) and ethnicity. Subjects with familial adenomatous polyposis, ulcerative colitis, Crohn's disease or any other previous malignancy were excluded from the study.
Methods

Study subjects
Genotyping
Genomic DNA was isolated from the peripheral blood of the study subjects by using QIAamp DNA Blood Mini Kit (QIAGEN, Germany) according to the manufacturer's protocol. Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method was then used to genotype the polymorphisms. Amplification of the genomic fragment containing both of the polymorphisms were performed by using Phusion High-Fidelity PCR Master Mix (Thermo Scientific, Finland) with a single pair of PCR primers (forward, 5 0 -GGT CCT TAA GGT CCA ATC G-3 0 ; reverse, 5 0 -GTT GTG GAT ACC TTG CAC TA-3 0 ). The PCR conditions consisted of an initial denaturation step at 98°C for 30 s, followed by 35 cycles of denaturation (98°C for 5 s), annealing (63°C for 5 s) and extension (72°C for 5 s), and a final extension at 72°C for 5 min. The 200-bp product generated was purified by using QIAquick PCR Purification Kit (QIAGEN, Germany), followed by digestion with BfaI and TspRI restriction enzymes (New England Biolabs, USA) for genotyping of the NFKBIA -826C[T and -881A[G polymorphisms, respectively. For the former, PCR amplicons containing the homozygous wild-type (CC) genotype was cleaved into two fragments of 180 bp and 20 bp, while those with the homozygous variant genotype (TT) was uncleaved and remained 200 bp (Fig. 1) . Heterozygotes showed all the three bands on agarose gel. For the -881A[G polymorphisms, the homozygous wild-type genotype (AA) did not contain TspRI restriction site; hence, the PCR product of 200 bp remained undigested. On the other hand, the homozygous variants were cleaved into two fragments of 129 and 71 bp, and heterozygotes showed all three bands (Fig. 1) . The genotypes were confirmed by sequencing of approximately 10 % of randomly chosen purified PCR products, and a 100 % concordance rate was achieved.
Statistical analysis
Statistical analysis was carried out by using SPSS version 19. Deviation of the polymorphic genotype distribution from the Hardy-Weinberg equilibrium (HWE) was tested using a chi-square goodness-of-fit test. Linkage disequilibrium was examined as described [25] . One-way analysis of variance (ANOVA) was used to evaluate the significance of the differences between the cases and controls in terms of gender, ethnicities, age, as well as genotype and allele frequencies of the polymorphisms. The association of the polymorphic genotypes with CRC risk was determined by deriving odds ratios (ORs) and the corresponding 95 % confidence intervals (CIs) from unconditional binary logistic regression analysis, with the homozygous wild-type genotype serving as the reference (OR 1.00). P \ 0.05 was considered significant in the analyses.
Results
Characteristics of study subjects
The characteristics of the study subjects are shown in Table 1 . A total of 237 cases and 237 controls were recruited into this study. Among the cases, 129 (54.4 %) were males and 108 (45.6 %) were females. On the other hand, among the controls, 123 (52.3 %) were males and 114 (47.7 %) were females. No significant difference in gender was observed between cases and controls (P = 0.581). The age range of the cases was 27-94 years old, with a mean of 61.5 ± 12.8 years and a median of 62 years, while the age range of the controls was 30-84 years old, with a mean of 58.0 ± 11.0 years and a median of 58 years. Despite the presence of a significant difference between the ages of the cases and controls (P \ 0.01), the difference in the mean ages of both groups of the study subjects were 3.3 years, which was still within our initial intention of matching the subjects by 5-year age difference. Among the cases, 182 (76.8 %) were Malays, 46 (19.4 %) were Chinese and 9 (3.8 %) were Indians, while 200 (84.4 %), 28 (11.8 %), and 9 (3.8 %) of the controls were of Malay, Chinese and Indian ethnicities, respectively. No significant difference was observed between cases and controls in terms of ethnicity (P = 0.07).
Distribution of genotype and allele frequencies of NFKBIA polymorphisms
The distribution of genotype and allele frequencies of NFKBIA -826C[T and -881A[G polymorphisms are shown in Table 2 showed an identical CRC risk association profile ( Table 3) . The heterozygous genotypes of the polymorphisms were associated with a decreased risk of CRC, although the association was not statistically significant (OR 0.84, 95 % CI 0.56-1.26, P = 0.40). Likewise, no statistically significant observation was found for the positive association of the homozygous variant genotypes of NFKBIA and CRC risk (OR 1.54, 95 % CI 0.50-4.82, P = 0.45).
The results obtained were also stratified by ethnicity, and the CRC risk association is shown in Table 4 . As the numbers of subjects of Chinese and Indian ethnicities were too small for sufficiently powered analysis to be made, they were categorized together as non-Malays in the analysis. The risk association profile of Malays was similar to the overall risk association profile of all the ethnic groups combined. The heterozygous genotypes of the two polymorphisms were associated with a reduced CRC risk (OR 0.81, 95 % CI 0.52-1.26), while the variant genotypes were associated with an increased risk of CRC (OR 1.25, 95 % CI 0.37-4.19), although both associations were statistically not significant (P heterozygous = 0.35, P variant = 0.72). On the contrary, for the non-Malay group, a positive CRC risk association was observed for the heterozygous genotypes (OR 1.35, 95 % CI 0.45-4.06). Nonetheless, the association was also not statistically significant (P = 0.59). The association between the homozygous variant genotypes of the polymorphisms and the risk of CRC could not be computed due to the absence of individuals carrying the genotypes in the control group.
In addition, when the results were stratified by the gender, no significant association was observed for the male subjects (P heterozygous = 0.37, P variant = 0.67), although it was found that the heterozygous genotypes of the polymorphisms conferred a slightly increased risk of CRC (OR 1.3, 95 % CI 0.73-2.30) and the homozygous variant genotypes conferred a protective role against CRC (OR 0.67, 95 % CI-0.11-4.13). Similarly, no statistically significant risk association was found for the homozygous variant genotypes among the females (OR 2.73, 95 % CI 0.53-13.97, P = 0.21). Interestingly, however, the gender-wise stratification analysis revealed a significant inverse association between the heterozygous genotypes of NFKBIA and the risk of CRC among females (OR 0.53, 95 % CI 0.29-0.97, P = 0.04) ( Table 5 ).
Discussion
The inhibitor of kappa B (IjB) family of inhibitory proteins plays an central role in regulating the nuclear factorkappa B (NF-jB) signaling pathway, which has been implicated in various carcinogenic processes, including immune response, cell proliferation, apoptosis, angiogenesis and perhaps most notably, inflammation [10] . With the exceptions of proliferating T cells, B cells, thymocytes, [11, 26] . In the presence of pro-inflammatory stimuli, IjB kinases (IKKs) phosphorylate the serine residues of IjBs in the canonical pathway, rendering IjBs for destruction via the ubiquitin-dependent pathway [26, 27] . This results in the activation, nuclear translocation and aberrant functioning of NF-jB, leading to oncogenesis. Indeed, such phenomenon has been observed in most cancer cell lines and tissues, including those of the pancreas [12] , colon and rectum [13, 14] , stomach [15] , breast [16] , liver [17] and prostate [18] , which highlights the importance of NF-jB signaling in carcinogenesis, and of IjB in circumventing tumorigenesis. As such, polymorphisms in the genes within the NF-jB and its inhibitory pathways could play an influencing role in cancer risk. Indeed, our previous study has established an association between the variant genotype of NFKB1 and CRC risk [28] . In mammals, the evolutionary conserved family of IjB consists of seven members, namely IjBa, IjBb, IjBc, IjBe, Bcl-3, and the precursor proteins p100 and p105 [29] . Among these, IjBa represents the most abundant form of the family and serves as an essential requirement for the normal inhibition of NF-jB [30] . IjBa is encoded by the NFKBIA gene on chromosome 14q13, which is located close to the inflammatory bowel disease-4 (IBD4) locus [31] . We therefore hypothesized that the interindividual variations within the NFKBIA gene could modulate the risk of CRC. Hence, promoter polymorphisms of NFKBIA which could potentially affect the transcription of the gene were selected for evaluation in the present study.
Indirect evidences have shown that the variant alleles of -826C[T and -881A[G polymorphisms were responsible for the decreased promoter activity of the gene [32] . The -826C[T polymorphism is located within a putative binding site of GATA-2, and as such, the C/T substitution could disrupt the binding of the transcription factor [33] . On the other hand, it has been suggested that the -881A[G polymorphism could alter the binding ability of retinoic acid-related orphan receptor a (RORa) transcription factor, which has been implicated in carcinogenesis [34] . Based on these, we hypothesized that an association may exist between the -826C[T and -881A[G polymorphisms and CRC risk.
However, our results indicated that there was no significant difference between the cases and controls in terms of genotypic distribution. This observation was in agreement with He et al. [22] and Cheng et al. [23] , who studied the association of these two polymorphisms with hepatocellular carcinoma in China and Taiwan, respectively. However, Lin et al. [24] reported that the homozygous wild-type genotypes of these two polymorphisms were significantly overrepresented in Taiwanese oral cancer patients and the heterozygous genotypes were significantly overrepresented in cancer-free controls. In addition, the present study also established that the two polymorphisms were in complete and perfect linkage disequilibrium. All the three authors above did not test for linkage disequilibrium in their analysis, but He et al. [22] reported a slightly different genotypic distribution between the two polymorphisms. All these differences highlight the variations in genotypic distribution of the polymorphisms across different populations and cancer types.
Our results also showed no evidence of an association between the polymorphisms and the risk of CRC. The lack of cancer risk association observed was in concordance with Cheng et al. [23] , but not with the other two authors mentioned above. He et al. [22] reported an association between -826TT and -881AG genotypes and the risk of hepatocellular carcinoma, while Lin et al. [24] reported an association between the variant genotypes of the two polymorphisms and oral cancer risk. These inconsistencies in risk association could be attributed to the different backgrounds of the study subjects in different studies. Indeed, our results also indicated that the heterozygous genotypes of the polymorphisms conferred opposing effects (risk vs. protective) to Malays and non-Malays when ethnic-based stratification was performed. Interestingly, we also found a significant inverse association between female heterozygotes and CRC risk when the results were stratified by gender. This observation suggests the important role of gender as a major determinant in colorectal carcinogenesis.
In conclusion, our results indicated a female-specific inverse association of the heterozygous genotypes of NFKBIA -826C[T and -881A[G polymorphisms with the risk of CRC. To the best of our knowledge, this is the first study evaluating the association between the polymorphisms and the risk of CRC in Malaysian population. To validate our findings, further replicative studies with a larger sample size are warranted.
